Mark Boslet
Patamar Capital has raised $23.6 million toward a $150 million venture-capital fund, according to a filing with the SEC.
Patamar Capital has raised $23.6 million toward a $150 million venture-capital fund, according to a filing with the SEC.
Northgate Capital has set out to raise a $120 million venture-capital fund, according to a filing with the SEC.
Northgate Capital has set out to raise a $120 million venture-capital fund, according to a filing with the SEC.
Clinical approvals are lifting confidence in gene editing and gene therapy, triggering a new wave of investment. Could this be healthcare’s new new thing?
MetaProp has set out to raise a $100 million third investment fund, according to a filing with the SEC.
Santé Ventures said it raised a $250 million third fund that is 79 percent larger than its second fund and aimed at maintaining ownership levels in its most successful portfolio companies. The life sciences fund will target investments in 20 to 25 companies, was oversubscribed by 25 percent, and attracted more than 30 LPs. Among […]
Sovereign wealth funds continued to pour money into private technology companies last year, accelerating a multi-year shift away from public markets as investment opportunities in private startups turned more exciting. These well-heeled investors steered $3.4 billion into 44 direct private technology deals worldwide in 2018, an almost 2.5x increase in capital over 2017, according to […]
The Riverside Company has raised $29.4 million toward a $50 million second opportunity fund, according to a filing with the SEC.
Jim Breyer will leave the Harvard Corp. at the end of June after six years of service, according to a report in The Harvard Gazette.